Clinical Trial Update: The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the use of botulinum toxin for myofascial pain syndrome, with Phase 1 and Phase 2 components, currently completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Yassir R. Al-khannaq | Conditions: Myofacial Pain Syndrome | Phase 1, Phase 2 | Status: COMPLETED